medicine2 papersavg year 2026quality 5/5

clinical therapy patient predictions synergistic

Research gap analysis derived from 2 medicine papers in our local library.

The gap

AetherCell's drug synergy predictions are benchmarked against DrugComb portal data, but systematic comparison of predicted versus experimentally validated synergistic combinations in patient-derived organoids and primary tumor samples is missing. This gap limits clinical translation for personalized combination therapy design.; Identification of the most responsive patient populations for MSC therapy is needed to improve clinical efficacy.

Research trend

Emerging — attention growing, methods still coalescing.

Supporting evidence — 2 representative gaps

  • AetherCell: A generative engine for virtual cell perturbation and in vivo drug discovery (2026) · doi

    AetherCell's drug synergy predictions are benchmarked against DrugComb portal data, but systematic comparison of predicted versus experimentally validated synergistic combinations in patient-derived organoids and primary tumor samples is missing. This gap limits clinical translation for personalized combination therapy design.

    Keywords: drug synergy prediction DrugComb patient-derived organoids primary tumors combination therapy personalized medicine
  • Mesenchymal stromal cells in Rheumathology: Recent findings (2026) · doi

    Identification of the most responsive patient populations for MSC therapy is needed to improve clinical efficacy.

    Keywords: identification responsive patient populations therapy needed improve clinical efficacy

Working on this gap? Publish with us.

Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.

Related gaps in medicine

Command palette

Jump anywhere, run any action.